Patent ductus arteriosus (PDA) remains a prominent clinical challenge in the management of preterm infants. During fetal life, the ductus arteriosus diverts blood away from the underdeveloped lungs, ...

“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

Babies born prematurely can have a number of complications at birth, simply because they are brought into the world before their organs are fully developed. One complication is called patent ductus ...

The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement that provides best-practice guidance for the treatment of patent ductus arteriosus (PDA) using ...

Miami-based Nicklaus Children’s Heart Institute is now performing bedside transcatheter patent ductus arteriosus (PDA) closures for newborns. The minimally invasive procedure is done directly in the ...

The persistence of the ductus arteriosus in preterm infants is a well‐documented contributor to morbidity, as the failure of this fetal vessel to close can result in significant haemodynamic ...

After birth, the pulmonary arterioles dilate and the right heart pressures drop. The left heart pressures increase as the low resistance placenta is replaced by the high-resistance systemic ...

Once a PDA is suspected or confirmed, the 2 main questions are (1) how to treat and (2) when to treat a particular infant This clinical controversy recently was the subject of an excellent systematic ...